Laminar Pharmaceuticals
Spain - Palma de MallorcaPharmaceutical
Focus: Laminar Pharmaceuticals is a Spain-based biotech company specializing in membrane lipid therapy and synthetic fatty acids, with a focused pipeline in neurology and cardiovascular indications. The company is publicly listed but operates as a small, research-stage organization.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Laminar Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow Laminar Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
6 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Left Atrial Appendage Closure
Atrial FibrillationClinical Trials (1)
NCT04807283Evaluating the Safety and Effectiveness of the Laminar Left Atrial Appendage Closure System
N/AHelp build intelligence for Laminar Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.